Testing effectiveness (Phase 2)Active Not RecruitingNCT06694701
What this trial is testing
Emapalumab Treatment For Anticipated Clinical Benefit In Sepsis Driven By The Interferon-Gamma Endotype (The EMBRACE Trial)
Who this might be right for
Sepsis
Hellenic Institute for the Study of Sepsis 75